IDM Pharma Gets $12.8 in PIPE

Irvine-based IDM Pharma announced today that it has closed a private placement, raising $12.8M. The publicly traded firm said that investors in the round included Palo Alto Investors, along with existing investor Alta Partners. IDM Pharma is a biopharmaceuticals firm focused on treating cancer.